About us
About C3 Glomerulopathy News
C3 Glomerulopathy News is a news and information website for people living with C3 glomerulopathy (C3G), their caregivers, and anyone following the science. We report on research, treatments, and clinical trials; explain the condition in plain language; and publish first-person columns from people affected by C3G.
The site launched in November 2026 as part of the Bionews network of rare disease communities.
What you will find here
- News: Reporting on research, clinical trials, approvals, and policy that affect the C3G community
- Disease guides: Plain-language pages on causes, symptoms, diagnosis, treatment, prognosis, and approved and experimental treatments
- Living with C3G: Pages on fatigue, fitness, traveling, vaccination, alcohol consumption, and disease management
- Columns: Personal perspectives from patients and caregivers
- Newsletter: Regular updates via email
- Forums: Moderated discussion boards launch later this year; members can ask questions and compare experiences with treatments, trials, and care teams
How our content is made
News articles and disease guides are written by science writers with a master’s or doctoral degree in the life sciences. Every article is fact-checked by PhD science editors or vetted through our medical review process before our veteran copy editing team reviews it for clarity, style, and grammar. Columns are written by people directly affected by C3G and are also edited and fact-checked.
Advertisers and sponsors do not influence what we publish. Read our Editorial Policy and Corrections Policy for the full standards.
Meet the team
Every article on C3 Glomerulopathy News identifies the writer. Here are the people behind our reporting.
Science writers
Science editor
Columnists
Columns are personal perspectives from patients and caregivers. They reflect the writer’s own experiences and are not medical advice or the views of C3 Glomerulopathy News or Bionews.
Living with C3G or caring for someone who does? Tell us your story idea.
Part of the Bionews network
C3 Glomerulopathy News is published by Bionews, Inc., which has built condition-specific news and community sites for patients and caregivers with rare diseases since 2013. Listed below are some of our other communities that may include information on kidney health and be of interest to the C3G community. See all Bionews patient communities.
- aHUS News (atypical hemolytic uremic syndrome)
- Amyloidosis News Today
- ANCA Vasculitis News (anti-neutrophil cytoplasmic antibodies)
- Fabry Disease News
- IgA Nephropathy News
- IgG4-RD News (immunoglobulin G4-related disease)
- Lupus News Today
Important information
This site is a news and information resource. It does not give medical advice, diagnosis, or treatment. Talk to your doctor or another qualified health provider about any medical questions, and never delay seeking professional advice because of something you read here.
Stay connected
Subscribe to our newsletter · Contact us · Facebook · Threads · Instagram
Last updated: Nov. 2, 2026